Biotech has been very hot this year as one of the fastest growing tech sectors as costs have plummeted, allowing innovation to speed up and bring us exciting innovations in health. But it’s been a bit of a rollercoaster ride for investors. The many Theranos scandals became a primer on what not to do when building a billion-dollar biotech startup and then we had exciting IPO’s (and… Read More